Related Experiment Video

Updated: Apr 22, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K

Receptor-type protein tyrosine phosphatases in cancer

Yu Du1, Jennifer R Grandis

  • 1Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. jgrandis@pitt.edu.

Chinese Journal of Cancer
|October 18, 2014
PubMed

Insights

Receptor-type protein tyrosine phosphatases (PTPRs) are crucial in cell signaling and cancer. Genetic and epigenetic changes in PTPRs impact cancer progression, offering potential as biomarkers and therapeutic targets.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Protein tyrosine phosphatases (PTPs) regulate critical cell functions like proliferation and apoptosis.
  • Receptor-type protein tyrosine phosphatases (PTPRs) are a key subgroup of PTPs involved in cell signaling.
  • PTPRs share a transmembrane domain, influencing their function and target specificity.

Purpose of the Study:

  • To review genetic and epigenetic alterations of PTPRs in cancer.
  • To examine the consequences of PTPR alterations across various cancer types.
  • To summarize the utility of PTPRs as prognostic/predictive biomarkers and therapeutic targets.

Main Methods:

  • Literature review of genetic and epigenetic alterations in PTPRs.
  • Analysis of PTPR roles in cancer cell signaling pathways.
  • Synthesis of current research on PTPR biomarkers and therapeutic strategies.

Main Results:

  • PTPRs undergo genetic (mutation, deletion, amplification) and epigenetic (promoter methylation) alterations in cancer.
  • These alterations have significant consequences on cancer development and progression.
  • PTPRs show promise as prognostic and predictive biomarkers.
  • PTPRs represent potential direct targets for cancer therapy.

Conclusions:

  • Understanding PTPR alterations in cancer is vital for advancing therapeutic strategies.
  • PTPRs are critical regulators of cell signaling with significant implications in oncology.
  • Targeting PTPRs may offer novel avenues for cancer treatment.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

850

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K